Synonyms:
Reflex sympethatic Dystrophy Syndrome (RSDS), Sudeck's Atrophy, Causalgia, Shoulder-Hand Syndrome, Posttraumatic Dystrophy, Sympathetic maintained pain syndrome
History:
-
Recognized since the Civil War when it was called causalgia, a name chosen to describe intense, burning extremity pain after an injury.
-
Bonica coined the term reflex sympathetic dystrophy in 1953
Incidence:
1% of all conservatively treated distal radius fractures and up to 5% of operatively treated fractures.
Types:
-
CRPS type I
-
secondary to an identifiable neurologic compression or injury.
-
e.g. ulnar nerve axonotemesis or a superficial radial nerve injury due to trauma from an external fixator pin.
-
-
CRPS type II
-
no identifiable neurological injury
-
sympathetically mediated pain
-
Stages:
Acute:
-
6-12 wks
-
persistent burning pain
-
trivial injury followed by severe & out of proportion pain
-
Localised pain, later spreads throughout extremity
-
Hypersensitivity to light touch
-
Extremity swollen & warm
-
Excessive perspiration
Dystrophic
-
Affected joint ROM restricted
-
Involved area becomes cool
Atrophic
-
Skin & muscle atrophy
-
Skin dry, shiny, glossy
-
Stiffness, intractable pain persists several weeks
Diagnosis:
-
Identify for CRPS type I or CRPS type II.
-
determine if it is a treatable source (type I).
-
Persistent burning pain after an injury is characteristic.
-
most common lesion with type I is median nerve injury, due to direct trauma or an undiagnosed compressive neuropathy.
-
causes are injury to the ulnar nerve, the superficial radial nerve, the intercarpal ligament, or the triangular fibrocartilage.
-
delayed union, incomplete union, and nonunion may also contribute to symptoms.
-
X-ray – Patchy Osteoporosis
-
Peripheral nerve conduction studies e.g. compression points around the elbow are useful, also evaluate the ulnar nerve.
-
MRI may show an incomplete union, carpal injuries, or TFCC injury.
-
Arthroscopic reveal arthrofibrosis and/or TFCC injuries.
-
Bone Scan +ve, showing regional uptake reflects ncreased blood flow
Treatment:
-
Prevention, immediate attention, control pain & swelling.
-
Restoration of motion by exercise
-
Active use of extremity despite pain
-
Edema control by limb elevation
-
Physiotherapy
-
Drugs: antidepressants, corticosteroids, calcium channel blockers
CRPS Type I:
Surgical treatment:
-
Neurolysis aimed at external compression of the median and ulnar nerve injuries.
-
Adjunctive grafting or Barrier wrapping for injury to sensory branches of the superficial radial or dorsal ulnar nerve.
-
Neuroma resection proximally and nerve stump can be buried in appropriate soft tissue.
-
External bone stimulators or revision osteosynthesis for an incomplete union.
CRPS type II
-
Multifaceted, aimed at restoring ANS control and improving physical function.
-
Early recognition and regional blockade with physical therapy is useful.
Medical management
-
guided by the appearance of the hand and wrist (Early phases marked by erythema and swelling, later phases, they may appear cool and atrophic.
-
For warm, swollen erythematous hand, treatment include gabapentin, selective serotonin reuptake inhibitors, or clonidine hydrochloride.
-
In later stages, the aim is to improve blood flow, using nifedipine or selective serotonin reuptake inhibitors.
Physical therapy
-
mobilizing the wrist and digits.
-
Focus is to improve wrist extension, causing greater mechanical advantage.
-
Adjunctive modalities such as dynamic or serial static splinting may prove effective at mobilizing the wrist and the metacarpophalangeal joints.
Prognosis
-
Recovery after CRPS treatment varies.
-
the prognosis for CRPS type I is better than that of CRPS type II.
-
When the syndrome continues for more than 1 year, it is likely that residual impairment will be present.
-
Regardless of the treatment afforded, patients experience delayed recovery.
CLASSIFICATION OF CRPS
ReplyDeleteCRPS I - (RSD) PAIN SYNDROME WITH LOSS OF FUNCTION AND AUTONOMIC DYSFUNCTION WITHOUT ANY NERVE DAMAGE
CRPS II ( CAUSALGIA ) – SYNDROME CAUSED BY FRANK NERVE DAMAGE.